Financial Performance Highlights - VONB increased by 14% to $2,838 million[11], driven by broad-based growth across 13 markets[49] - OPAT per share increased by 12%[11], reflecting higher earnings and ROE[41] - UFSG per share increased by 10% to $3,569 million[11] - Interim dividend per share increased by 10% to 49.00 HK cents[47] - $3.7 billion was returned to shareholders[13] Key Growth Drivers - AIA Hong Kong's VONB grew by 24% to $1,063 million[15], supported by agency and bancassurance channels[15] - AIA China's VONB reached $743 million in 1H25[17], with a VONB margin exceeding 65%[17] - ASEAN combined VONB increased by 20%[22], driven by traditional protection products[22] - Tata AIA Life's VONB increased by 38%[25], positioning it as a top 3 private life insurer in India[25] Strategic Initiatives - The company is deploying Gen AI at scale to accelerate growth across core platforms[38] - The company is focused on integrated healthcare strategy to make healthcare more accessible, affordable, and effective[35] - The company is building a differentiated and sustainable bancassurance model in China, focusing on HNW customers[104] Capital Management - The company maintains a strong shareholder capital ratio of 219% after returning $3.7 billion to shareholders[47, 82] - The company has a disciplined capital deployment strategy, with $22 billion returned since 2022[81] - The company targets a payout ratio of 75% of annual net free surplus generation[75]

Investment Rating - The investment rating for AIA Group Limited is "Buy" (maintained) [1] Core Insights - The new business value (NBV) for the first quarter of 2025 increased by 13% year-on-year, indicating a recovery in the new business value rate [7] - The annualized new premium (ANP) reached 2.62 billion USD, reflecting a 7% year-on-year growth [7] - The NBV margin improved to 57.5%, up by 3 percentage points year-on-year, with expectations for continued recovery in 2025 [7] - The company has initiated a share repurchase plan of 1.6 billion USD, which began on April 14 [7] - The forecast for after-tax operating profit for 2025-2027 is maintained at 7.24 billion, 7.98 billion, and 8.71 billion USD respectively, indicating a positive outlook [7] Financial Performance Summary - Insurance revenue is projected to grow from 19.31 billion USD in 2024 to 21.90 billion USD in 2027, with a compound annual growth rate (CAGR) of approximately 4.43% [20] - After-tax operating profit is expected to increase from 6.61 billion USD in 2024 to 8.71 billion USD in 2027, reflecting a growth trajectory [20] - Earnings per share (EPS) is forecasted to rise from 0.64 USD in 2024 to 0.92 USD in 2027 [20] - The price-to-earnings (P/E) ratio is projected to decrease from 11.00 in 2024 to 7.66 in 2027, indicating potential undervaluation [20]